FIELD: chemistry.
SUBSTANCE: invention relates to a heterocyclic compound of the formula (I), or a pharmaceutically acceptable salt thereof, wherein the group represented by the formula is a group represented by the formula: ; R1, in each case, independently, is halogen, unsubstituted alkyl, substituted alkenyl, substituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or substituted amino; wherein the said radical values are disclosed in the invention formula; m is an integer of 2 or 3; R2 is hydrogen; X is -O-; and Y is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; where the said values of the radical are disclosed in the invention formula. The invention also relates to the pharmaceutical composition based on a compound of theformula (I) and the method of preventing or treating diabetes based on the compound use of the formula (I). .
EFFECT: new compounds have been produced that have an activating effect on adenosine monophosphate-activated protein kinase.
18 cl, 87 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC DERIVATIVE HAVING ACTIVATING AMPK ACTIVITY | 2015 |
|
RU2700703C2 |
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
TRICYCLIC COMPOUNDS AS INHIBITORS OF IMMUNOSUPPRESSION MEDIATED BY TRYPTOPHAN METABOLIZATION | 2014 |
|
RU2667509C2 |
TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2486186C2 |
IMIDAZOQUINOLINE SUBSTITUTED PHOSPHORIC ACID ESTER AS AGONIST, ITS PREPARATION AND USE | 2020 |
|
RU2812182C1 |
ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS | 2013 |
|
RU2653497C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
CFTR REGULATORS AND METHODS OF USING | 2016 |
|
RU2730855C2 |
BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | 2018 |
|
RU2776846C2 |
Authors
Dates
2017-11-15—Published
2011-09-08—Filed